Histology-Related Associations of ERCC1, RRM1, and TS Biomarkers in Patients With Non–Small-Cell Lung Cancer: Implications for Therapy

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e318287c3c5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

RRM1 Expression and the Clinicopathological Characteristics of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine

OncoTargets and Therapy
OncologyPharmacology
2018English

ERCC1 and Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Promoter Polymorphisms of TOP2A and ERCC1 Genes as Predictive Factors for Chemotherapy in Non‐small Cell Lung Cancer Patients

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Advances in Immune Therapy for Non Small Cell Lung Cancer

Medical Diagnosis
2016English

Plasma microRNAs as Potential Biomarkers for Non-Small-Cell Lung Cancer

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy